Status:
COMPLETED
Bisphenol Role in the Pathogenesis of PCOS
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Kasr El Aini Hospital
Cairo University
Conditions:
PCOS
Eligibility:
FEMALE
18-40 years
Brief Summary
Polycystic ovary syndrome (PCOS) is the most common and the most heterogeneous endocrine disorder in premenopausal women. Its prevalence is estimated from 5 to 10% depending on the diagnosis' criteria...
Detailed Description
Bisphenol A is formed from acetone and phenol, it is used in production of epoxy resin, polyster resins and polyvarbonate resins. Epoxy resins are used in plastics, adhesives, and structural composite...
Eligibility Criteria
Inclusion
- Age group: 18-40
- Females
- Diagnosed a case of polycystic ovary syndrome
Exclusion
- • Female patients with other acute or chronic illness
- Cardiovascular disease
- Neoplasms
- Current smoking, diabetes mellitus,
- Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).
Key Trial Info
Start Date :
February 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2020
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03436108
Start Date
February 10 2019
End Date
January 20 2020
Last Update
January 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah
Giza, Egypt